StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.50−0.20 (-11.76%)

Close on Nov 17, 2026Market cap $12.22MP/E –Yield –

Niki BioSolutions gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2023 it was 2.4%, against 6.2% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 20232.4%−3.7
FY2022Dec 31, 20226.2%+0.9
FY2021Dec 31, 20215.3%–

More Niki BioSolutions figures

See a number that looks wrong?